Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 4 6Phase 3 4Phase 2 2Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 4Thoracic 2Head & Neck 2Gynecologic 2Gastrointestinal 2Classical hematology 1

Conditions

Colorectal Neoplasms 1295Pancreatic Neoplasms 819Carcinoma, Hepatocellular 782Stomach Neoplasms 754Rectal Neoplasms 565Esophageal Neoplasms 452Colonic Neoplasms 414Esophageal Squamous Cell Carcinoma 277Neoplasm Metastasis 263Cholangiocarcinoma 251Liver Neoplasms 219Neoplasms 200Biliary Tract Neoplasms 179Adenocarcinoma Of Esophagus 139Gastrointestinal Stromal Tumors 108Gallbladder Neoplasms 96Adenocarcinoma 94Breast Neoplasms 91Gastrointestinal Neoplasms 89Carcinoma, Non-Small-Cell Lung 87Bile Duct Neoplasms 69Sarcoma 67Lung Neoplasms 64Ovarian Neoplasms 60Anus Neoplasms 59Melanoma 54Uterine Cervical Neoplasms 52Carcinoma 48Digestive System Neoplasms 45Prostatic Neoplasms 40

Interventions

trimebutine 3-thiocarbamoylbenzenesulfonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Agnosia × Gastrointestinal × Clear all
NCT05114213 2025-12-05

MASPAC

Ludwig-Maximilians - University of Munich

Phase 2 Terminated
9 enrolled
Gastrointestinal

Agnosia, Pancreatic Neoplasms

NCT01926444 2019-05-08

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

gicare Pharma Inc.

Phase 2 Completed
308 enrolled 14 charts
Gastrointestinal

Agnosia, Colonic Diseases, Neoplasms, Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡